Literature DB >> 33965333

Effect of varicoceles on spermatogenesis.

Caroline Kang1, Nahid Punjani2, Richard K Lee3, Philip S Li4, Marc Goldstein5.   

Abstract

Varicoceles are dilated veins within the spermatic cord and a relatively common occurrence in men. Fortunately, the large majority of men are asymptomatic, however, a proportion of men with varicoceles can suffer from infertility and testosterone deficiency. Sperm and testosterone are produced within the testis, and any alteration to the testicular environment can negatively affect the cells responsible for these processes. The negative impact of varicoceles on testicular function occurs mainly due to increased oxidative stress within the testicular parenchyma which is thought to be caused by scrotal hyperthermia, testicular hypoxia, and blood-testis barrier disruption. Management of varicoceles involves ligation or percutaneous embolization of the dilated veins. Repair of varicoceles can improve semen parameters and fertility, along with serum testosterone concentration. In this review, we discuss the pathophysiology of varicoceles, their impact on testicular function, and management.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Male infertility; Oxidative stress; Spermatogenesis; Testicular dysfunction; Testosterone deficiency; Varicocele

Mesh:

Substances:

Year:  2021        PMID: 33965333     DOI: 10.1016/j.semcdb.2021.04.005

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  2 in total

1.  Long noncoding RNAs regulated spermatogenesis in varicocele-induced spermatogenic dysfunction.

Authors:  Shangren Wang; Jiaqi Kang; Yuxuan Song; Aiqiao Zhang; Yang Pan; Zhexin Zhang; Yuezheng Li; Shuai Niu; Li Liu; Xiaoqiang Liu
Journal:  Cell Prolif       Date:  2022-03-17       Impact factor: 8.755

2.  Silencing CAMK2D Promotes the Proliferation of Spermatogonia in the Testis of Experimental Varicocele Rats.

Authors:  Songxi Tang; Peng Yang; Yilang Ding; Qiang Chen; Hailin Huang; Xi Chen; Huiliang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.